Potent Rifamycin-Sparing Regimen Cures Guinea Pig Tuberculosis as Rapidly as the Standard Regimen
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent Rifamycin-Sparing Regimen Cures Guinea Pig Tuberculosis as Rapidly as the Standard Regimen
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 8, Pages 3910-3916
Publisher
American Society for Microbiology
Online
2013-06-04
DOI
10.1128/aac.00761-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preliminary Pharmacokinetic Study of Repeated Doses of Rifampin and Rifapentine in Guinea Pigs
- (2013) Noton K. Dutta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis
- (2013) N. K. Dutta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifapentine Is Not More Active than Rifampin against Chronic Tuberculosis in Guinea Pigs
- (2012) Noton K. Dutta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
- (2012) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
- (2012) Ian M. Rosenthal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Modeling of Tuberculosis Drugs and its Impact on Optimization of Doses and Regimens
- (2012) Shashikant Srivastava et al. CURRENT PHARMACEUTICAL DESIGN
- Tuberculosis chemotherapy : Present situation, possible solutions, and progress towards a TB-free world
- (2012) PetrosC Karakousis et al. Indian Journal of Medical Microbiology
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
- (2012) S. E. Dorman et al. JOURNAL OF INFECTIOUS DISEASES
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose-Dependent Activity of Pyrazinamide in Animal Models of Intracellular and Extracellular Tuberculosis Infections
- (2011) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aerosolized Gentamicin Reduces the Burden of Tuberculosis in a Murine Model
- (2011) Chad J. Roy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New drugs for tuberculosis treatment
- (2011) Francesca Sánchez et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models
- (2011) Z. Ahmad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incidence of Moxifloxacin Resistance in Clinical Mycobacterium tuberculosis Isolates in Houston, Texas
- (2011) H. M. El Sahly et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
- (2011) Jamie Harper et al. JOURNAL OF INFECTIOUS DISEASES
- Dry Powder PA-824 Aerosols for Treatment of Tuberculosis in Guinea Pigs
- (2010) L. Garcia-Contreras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
- (2010) Zahoor Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters
- (2010) Z. Ahmad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig
- (2010) Z. Ahmad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global tuberculosis drug development pipeline: the need and the reality
- (2010) Zhenkun Ma et al. LANCET
- Dry Powder Nitroimidazopyran Antibiotic PA-824 Aerosol for Inhalation
- (2009) J. C. Sung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug‐Tolerant, Not Drug‐Resistant,Mycobacterium tuberculosisin the Guinea Pig
- (2009) Zahoor Ahmad et al. JOURNAL OF INFECTIOUS DISEASES
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis
- (2008) R. Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
- (2008) E. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
- (2008) L. E. Via et al. INFECTION AND IMMUNITY
- Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates
- (2008) M. Mphahlele et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Metronidazole Lacks Activity againstMycobacterium tuberculosisin an In Vivo Hypoxic Granuloma Model of Latency
- (2008) Lee G. Klinkenberg et al. JOURNAL OF INFECTIOUS DISEASES
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search